Kim, H.J.^a,*, Paul, F.^b, Lana-Peixoto, M.A.^c, Tenembaum, S.^d, Asgari, N.^e,f, Palace, J.^g, Klawiter, E.C.^h, Sato, D.K.ⁱ, De Seze, J.^j, Wuerfel, J.^b,k, Banwell, B.L.^l,m, Villoslada, P.ⁿ, Saiz, A.ⁿ, Fujihara, K.^o, Kim, S.-H.^a, The Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository, Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository

^aDepartment of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea
^bNeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine, Berlin, Germany
^cCIEM MS Research Center, Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil
^dDepartment of Neurology, National Paediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina
^eNeurobiology, Institute of Molecular Medicine, University of Southern Denmark, Denmark
^fDepartment of Neurology, Vejle Hospital, Denmark
^gDepartment of Clinical Neurology, John Radcliffe Hospital, Oxford, United Kingdom
^hDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
ⁱDepartment of Neurology, Tohoku University School of Medicine, Sendai, Japan
^jNeurology Department, Hôpitaux Universitaires de Strasbourg, France
^kInstitute of Neuroradiology, University Medicine Goettingen, Germany
^lDepartment of Pediatrics, Division of Neurology, Children's Hospital of Philadelphia, United States
^mDepartment of Neurology, University of Pennsylvania, United States
ⁿCenter of Neuroimmunology, Service of Neurology, Hospital Clinic and Institute of Biomedical Research August Pi Sunyer, Barcelona, Spain
^oDepartment of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan

^*Corresponding author